Hydrotropic solubilization of paclitaxel: Analysis of chemical structures for hydrotropic property

被引:149
作者
Lee, JW
Lee, SC
Acharya, G
Chang, CJ
Park, K [1 ]
机构
[1] Purdue Univ, Dept Pharmaceut, W Lafayette, IN 47907 USA
[2] Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA
关键词
hydrotropic agents; solubilization; poorly watersoluble drug; paclitaxel; structure-activity relationship;
D O I
10.1023/A:1024458206032
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To identify hydrotropic agents that can increase aqueous paclitaxel (PTX) solubility and to study the chemical structures necessary for hydrotropic properties so that polymeric hydrotropic agents can be synthesized. Methods. More than 60 candidate hydrotropic agents (or hydrotropes) were tested for their ability to increase the aqueous PTX solubility. A number of nicotinamide analogues were synthesized based on the observation that nicotinamide showed a favorable hydrotropic property. The identified hydrotropes for PTX were used to examine the structure-activity relationship. Results. N,N-Diethylnicotinamide (NNDENA) was found to be the most effective hydrotropic agent for PTX. The aqueous PTX solubility was 39 mg/ml and 512 mg/ml at NNDENA concentrations of 3.5 M and 5.95 M, respectively. These values are 5-6 orders of magnitude greater than the intrinsic solubility of 0.30+/-0.02 mug/ml. N-Picolylnicotinamide, N-allylnicotinamide, and sodium salicylate were also excellent hydrotropes for PTX. Solubility data showed that an effective hydrotropic agent should be highly water soluble while maintaining a hydrophobic segment. Conclusions. The present study identified several hydrotropic agents effective for increasing aqueous solubility of PTX and analyzed the structural requirements for this hydrotropic property. This information can be used to find other hydrotropic compounds and to synthesize polymeric hydrotropes that are effective for PTX and other poorly water-soluble drugs.
引用
收藏
页码:1022 / 1030
页数:9
相关论文
共 15 条
[1]   A MIXED MICELLAR FORMULATION SUITABLE FOR THE PARENTERAL ADMINISTRATION OF TAXOL [J].
ALKANONYUKSEL, H ;
RAMAKRISHNAN, S ;
CHAI, HB ;
PEZZUTO, JM .
PHARMACEUTICAL RESEARCH, 1994, 11 (02) :206-212
[2]   Hydrotropic solubilization - Mechanistic studies [J].
Coffman, RE ;
Kildsig, DO .
PHARMACEUTICAL RESEARCH, 1996, 13 (10) :1460-1463
[3]  
FLOYD AG, 1998, PHARM DOSAGE FORMS D, V2, P261
[4]  
FORD JL, 1986, PHARM ACTA HELV, V61, P69
[5]  
Goldspiel BR, 1997, PHARMACOTHERAPY, V17, pS110
[6]   Hydrotropic polymers: Synthesis and characterization of polymers containing picolylnicotinamide moieties [J].
Lee, SC ;
Acharya, G ;
Lee, J ;
Park, K .
MACROMOLECULES, 2003, 36 (07) :2248-2255
[7]  
Leung SYL, 2000, PROSTATE, V44, P156, DOI 10.1002/1097-0045(20000701)44:2<156::AID-PROS8>3.0.CO
[8]  
2-8
[9]  
Löbenberg R, 2000, DRUGS PHARM SCI, V106, P137
[10]   EFFECT OF HYDROTROPIC SUBSTANCES ON THE COMPLEXATION OF SPARINGLY SOLUBLE DRUGS WITH CYCLODEXTRIN DERIVATIVES AND THE INFLUENCE OF CYCLODEXTRIN COMPLEXATION ON THE PHARMACOKINETICS OF THE DRUGS [J].
MULLER, BW ;
ALBERS, E .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (06) :599-604